Literature DB >> 1400401

Cloning of human AMP deaminase isoform E cDNAs. Evidence for a third AMPD gene exhibiting alternatively spliced 5'-exons.

D K Mahnke-Zizelman1, R L Sabina.   

Abstract

Higher eukaryotes express multiple isoforms of AMP deaminase (EC 3.5.4.6). In humans, four AMP deaminase variants, termed M (muscle), L (liver), E1, and E2 (erythrocyte) can be distinguished by a variety of biochemical and immunological criteria. Previous molecular studies have reported two genes, AMPD1 and AMPD2, that produce isoform M and L transcripts, respectively. This study identifies a third human AMP deaminase gene, AMPD3. Nucleotide sequence alignments between AMPD3 cDNAs isolated from several human libraries indicate three different extreme 5'-ends. Alternate forms of the AMPD3 cDNAs contain a common 2301-bp open reading frame (ORF) and 3'-untranslated region of 1245 bp. Two of the three forms, however, exhibit additional 5'-end nucleotide sequences that would extend their respective ORFs by 21 and 27 nucleotides. RNase protection analyses and the partial characterization of human AMPD3 genomic clones demonstrate alternative splicing of three different 5'-terminal exons. Western blot analyses detect anti-E-specific immunoreactivity in affinity-purified extracts derived from the bacterial expression of a truncated AMPD3 cDNA. These results are discussed in relation to AMP deaminase isoform diversity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1400401

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Molecular characterization of adenosine 5'-monophosphate deaminase--the key enzyme responsible for the umami taste of nori (Porphyra yezoensis Ueda, Rhodophyta).

Authors:  Seiko Minami; Minoru Sato; Yoshihiro Shiraiwa; Koji Iwamoto
Journal:  Mar Biotechnol (NY)       Date:  2011-04-26       Impact factor: 3.619

2.  Isolation and regulation of piglet cardiac AMP deaminase.

Authors:  A M Hohl; C M Hohl
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

3.  Full-size form of human liver AMP-deaminase?

Authors:  M Szydlowska; Z Chodorowski; I Rybakowska; G Nagel-Starczynowska; K Kaletha
Journal:  Mol Cell Biochem       Date:  2004-11       Impact factor: 3.396

4.  The molecular basis of skeletal muscle weakness in a mouse model of inflammatory myopathy.

Authors:  William Coley; Sree Rayavarapu; Gouri S Pandey; Richard L Sabina; Jack H Van der Meulen; Beryl Ampong; Robert L Wortmann; Rashmi Rawat; Kanneboyina Nagaraju
Journal:  Arthritis Rheum       Date:  2012-11

5.  Regulation of rat AMP deaminase 3 (isoform C) by development and skeletal muscle fibre type.

Authors:  D K Mahnke-Zizelman; J D'cunha; J M Wojnar; M A Brogley; R L Sabina
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

Review 6.  Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency.

Authors:  M Gross
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

Review 7.  Molecular biology of AMP deaminase deficiency.

Authors:  M Gross
Journal:  Pharm World Sci       Date:  1994-04-15

8.  Expression patterns of AMP-deaminase and cytosolic 5'-nucleotidase genes in human term placenta.

Authors:  Anna Roszkowska; Jerzy Klimek; Krystian Kaletha
Journal:  Mol Cell Biochem       Date:  2007-12-30       Impact factor: 3.396

9.  Functionally distinct elements are required for expression of the AMPD1 gene in myocytes.

Authors:  T Morisaki; E W Holmes
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

10.  Characterization of human AMP deaminase 2 (AMPD2) gene expression reveals alternative transcripts encoding variable N-terminal extensions of isoform L.

Authors:  F Van den Bergh; R L Sabina
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.